[1] Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001,33: 464-470. [2] Ripoll C, Lastra P, Rincon D, et al. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis. Scand J Gastroenterol, 2012,47:204-211. [3] Schouten JN, Francque S, Van Vlierberghe H, et al. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth. Clin Transplant, 2012,26:E62-E70. [4] 唐长华, 李志斌, 刘芳, 等. MELD及其衍生评分系统对慢性乙型重型肝炎患者短期预后的预测价值. 传染病信息, 2011,24:282-285. [5] 沈美龙, 徐洪涛, 邢同京, 等. 终末期肝病模型联合白细胞介素15评分对慢性乙型肝炎预后预测. 中华临床医师杂志(电子版), 2011,5:6358-6362. [6] 钱志平, 廖粤斌, 王介非, 等. MELD评分对慢性乙型重型肝炎患者预后的评价作用. 肝脏, 2006,11:316-317. [7] 郭峰, 王晓波, 马燕, 等. 四种终末期肝病模型联合血清钠模型对慢加急性肝衰竭患者短期预后的评估价值. 肝脏, 2015,20:674-677. [8] 徐琴, 孙丽华, 张跃新, 等. MELD与改良MELD在评价慢性重型肝炎预后中的应用与比较. 实用临床医药杂志, 2014,18:36-39. [9] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 中华肝脏病杂志, 2013,21:177-183. [10] Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000,31:864-871. [11] 董飞波, 周健. 慢性乙型重型肝炎患者的整合终末期肝病模型短期预后分析. 中华肝脏病杂志, 2011,19:220-221. |